Peruvian Government Rejects AstraZeneca COVID-19 Vaccine Purchase Deal

The Peruvian government announced on Sunday that it refused to sign a COVID-9 vaccine purchase deal with AstraZeneca PLC because the company failed to provide sufficient information from its studies and offered minimal amounts of inoculations.

The Peruvian government announced on Sunday that it refused to sign a COVID-9 vaccine purchase deal with AstraZeneca PLC because the company failed to provide sufficient information from its studies and offered minimal amounts of inoculations.

During a press conference in Peruvian capital Lima, Prime Minister Walter Martos said that the government of President Martin Vizcarra had asked the company for information from its vaccine studies, but that it had not sent the information.

“The other labs have caught up with us accordingly, however AstraZeneca has not. They were offering us a very low quantity of vaccines compared with other laboratories that are offering us large quantities at lower costs,” Martos told local reporters.

He also said that despite a slowdown in the number of new virus infections in Peru, a second wave of the pandemic in the country is possible. AstraZeneca planned to conduct trials in Peru.

The rate of infections and deaths from COVID-19 in Peru has been slowing since September. As of Thursday, COVID-19 cases in Peru totaled 876,885, with 33,937 deaths.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.